Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2013
12/18/2013EP2398793B1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/18/2013EP2215087B1 Xinafoate salt of n4- (2,2-difluoro-4h-benzo [1,4] oxazin-3-one) - 6-yl] - 5-fluoro-n2 - [3-(methylaminocarbonylmethyleneoxy) phenyl] 2,4-pyrimidinediamine
12/18/2013EP2150539B1 Pyridazinone derivatives
12/18/2013EP2098517B1 Novel phenyl-isoxazol-3-ol derivative
12/18/2013EP1616864B1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
12/18/2013CN103459386A N-(1,2,5-oxadiazol-3-yl)pyridinecarboxamides and use thereof as herbicides
12/18/2013CN103459385A IL17 and IFN-[gamma] inhibition for the treatment of autoimmune inflammation
12/18/2013CN103459384A Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
12/18/2013CN103459380A Novel phenylpyridine derivative and drug containing same
12/18/2013CN103459379A Glycine transport inhibitor
12/18/2013CN103459377A Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
12/18/2013CN103450201A Preparation method of chiral 8-(3-aminopiperidine-1-yl)-xanthine
12/18/2013CN103450175A Conjugated dienes derivative and preparation method thereof and application as anti-cancer drug
12/18/2013CN103450174A Benzopyrone-phenyl-oxazolidone compounds as well as preparation methods and applications thereof
12/18/2013CN103450173A Pyrrolone-phenyl-oxazolidinone compounds as well as preparation methods and applications thereof
12/18/2013CN103450172A Preparation method of antipsychotic drug lurasidone
12/18/2013CN103450171A Novel immune adjustment compound, application thereof and medicine combination comprising same
12/18/2013CN103450170A Pyridine-containing 1,3,4-oxadiazole derivative, and preparation method and application thereof
12/18/2013CN103450169A Refining method of iloperidone
12/18/2013CN103450168A Acylhydrazone derivatives containing 1,3,4-oxadiazole and pyridine, and preparation method and use thereof
12/18/2013CN103450167A Acylhydrazone derivatives containing 1, 3, 4-oxadiazole and pyrazine ring and preparation method and uses thereof
12/18/2013CN103450132A Synthesis and preparation method of novel sulfanilamide-coumarin derivatives
12/18/2013CN103450117A Method for preparing 7, 10-dimethoxy taxane compound
12/18/2013CN103450092A Synthesis and preparation method of metronidazole-sulfanilamide derivatives
12/18/2013CN102143958B Pyridazine derivatives as SMO inhibitors
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101621998B Benzimidazole cannabinoid agonists bearing substituted heterocyclic group
12/18/2013CN101014587B Substituted biaryl piperazinyl-pyridine analogues
12/17/2013US8609838 Pyrimidine substituted purine derivatives
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013US8609657 Compounds
12/17/2013US8609656 Heteroarylphenylurea derivative
12/17/2013US8609648 Hepatitis C virus inhibitors
12/17/2013CA2749114C Heteroatom-containing cyclic compound
12/17/2013CA2729495C Pyrimidine derivatives as kinase inhibitors
12/17/2013CA2615751C N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof
12/17/2013CA2527583C Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/12/2013WO2013184757A1 Compounds and compositions for modulating egfr activity
12/12/2013WO2013184202A1 Fbxo3 inhibitors
12/12/2013WO2013182070A1 Drug for preventing or treating mycobacterial diseases
12/12/2013US20130331571 Glycine transporter-inhibiting substances
12/12/2013US20130331567 Modulators of atp-binding cassette transporters
12/12/2013US20130331419 Mineralocorticoid receptor antagonists
12/12/2013US20130331416 Dosage regimen for comt inhibitors
12/12/2013US20130331382 Pyridinone and Pyridazinone Derivatives
12/12/2013US20130331380 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
12/12/2013US20130331379 Process for the preparation of an orexin receptor antagonist
12/12/2013US20130331377 Diaminopyrimidine derivatives and processes for the preparation thereof
12/12/2013US20130331372 Cyclic Amine Substituted Oxazolidinone CETP Inhibitor
12/12/2013US20130331371 Azetidine Derivatives
12/12/2013US20130330365 Neprilysin inhibitors
12/12/2013CA2875966A1 Compounds and compositions for modulating egfr activity
12/12/2013CA2875305A1 Fbxo3 inhibitors
12/11/2013EP2670738A2 1,4 oxazines as bace1 and/or bace2 inhibitors
12/11/2013EP2670245A1 Alpha-ketoheterocycles and methods of making and using
12/11/2013CN103443098A Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
12/11/2013CN103443097A Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders
12/11/2013CN103443093A Novel compounds as histamine H3 receptor ligands
12/11/2013CN103443080A Sulfonamide compounds having TRPM8 antagonistic activity
12/11/2013CN103443079A Fluoro-pyridinone derivatives useful as antibacterial agents
12/11/2013CN103443078A Cyanoenamines and their use as fungicides
12/11/2013CN103443074A Heterocyclic amine derivatives
12/11/2013CN103442766A A 5-HT4 receptor agonist as a prokinetic agent
12/11/2013CN103442712A Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435605A Morpholine tetrazole compound, and preparation method and application thereof
12/11/2013CN103435604A Refining method of high-purity azilsartan
12/11/2013CN103435595A Acetylenic heteroaryl compounds
12/11/2013CN103435594A 2-amino-quinazolines PLK1 (Polo-like kinase1) inhibitor and application thereof
12/11/2013CN103435562A 6-substituted benzodiazepine-2,4-diketone compound and application thereof
12/11/2013CN102153538B Benzocyclodirivative
12/11/2013CN102040591B 7-phenyl quinolone compounds
12/11/2013CN101888999B Pyridylmethyl-sulfonamide compounds
12/11/2013CN101835755B Novel kinase inhibitors
12/10/2013US8604217 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
12/10/2013US8604209 Methods for preparing oxazolidinones and compositions containing them
12/10/2013US8604190 Hetero isonipecotic modulators of vanilloid VR1 receptor
12/10/2013US8604062 Process for the preparation of isoxazolyl-methoxy nicotinic acids
12/10/2013US8604061 2-aminooxazolines as TAAR1 ligands
12/10/2013US8604055 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
12/10/2013US8604042 Bi-aryl meta-pyrimidine inhibitors of kinases
12/10/2013US8604037 Therapeutic agents useful for treating pain
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8604030 Fused piperidine compound and pharmaceutical containing same
12/10/2013US8604023 1,4-benzodiazepinone compounds and their use in treating cancer
12/10/2013US8604022 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
12/10/2013CA2810655C Modulators of atp-binding cassette transporters
12/10/2013CA2608957C Pyrrolidine derivative or salt thereof
12/10/2013CA2608087C Methods for synthesizing heterocyclic compounds
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013181384A1 Solid state forms of aleglitazar sodium
12/05/2013WO2013181332A1 Nitric oxide donor neprilysin inhibitors
12/05/2013WO2013180403A1 Process for preparing gefitinib and an intermediate used for preparing thereof
12/05/2013WO2013180194A1 Fused heterocyclic compound
12/05/2013WO2013180193A1 Fused heterocyclic compound
12/05/2013WO2013180128A1 4-[4-(5-membered aromatic heterocyclic carbonyl ureide)phenyloxy]quinoline derivative
12/05/2013WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives
12/05/2013WO2013178569A1 Pyrrolidino heterocycles
12/05/2013WO2013178362A1 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma]
12/05/2013WO2013178075A1 N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and antitumor application thereof
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 647